VisAcT

1 stories · following the connections

Business

Telix Pharmaceuticals and CellSight Technologies Conclude Collaboration and License Agreement for VisAcT ImmunoPET Technology

By Nasdaq OMXSep 20, 2017, 1:46 AM UTC